The SKIN Conundrum: Why Beauty Health Co’s Stock Is Making Headlines Again

Jefferies has recently reduced Beauty Health Co (SKIN) stock to Hold rating, as announced on November 15, 2023, according to Finviz. Earlier, on November 14, 2023, William Blair had reduced the stock from a Outperform to Mkt Perform. The Benchmark Company also reduced Hold rating. Additionally, TD Cowen reduced Market Perform rating on November 14, 2023, with a target price of $2.50. Raymond James analysts, in their report published on November 14, 2023, also reduced Underperform rating for Beauty Health Co’s stock. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and market sentiment.


Sponsored

Beauty Health Co (SKIN) Stock Trading Recap

On Wednesday, Beauty Health Co (SKIN) stock saw a decline, ending the day at $1.77 which represents a decrease of $-0.02 or -1.12% from the prior close of $1.79. The stock opened at $1.76 and touched a low of $1.74 during the day, reaching a high of $1.83. The volume of shares traded was 1.32 million falling short of the average volume of 1.39 million.

SKIN Stock Performance and Moving Averages

In recent trading, Beauty Health Co (SKIN) stock price has shown some volatility, fluctuating 5.99% over the last five trades and 25.53% over the past 30 trades. This represents a notable shift from earlier in the year. Over the last six months, the stock has risen by -44.16%, and it has gained 4.12% in the previous three months. Currently, SKIN is trading at 9.53%, 11.97%, and -27.43% relative to its 20-Day, 50-Day, and 200-Day Simple Moving Averages, respectively.

As of the latest trading close, SKIN, a Consumer Defensive sector stock, is trading -65.76% below its 52-week high but remains 94.51% above its 52-week low. The Average True Range (ATR) (14 days) of 0.11 highlights the stock’s average volatility, providing insight into how much the price typically fluctuates. This measure is crucial for understanding potential price swings and assessing overall market risk.

Beauty Health Co’s Profitability and Valuation Ratios

Beauty Health Co’s profitability metrics reveal strong financial health. The company currently boasts an operating margin of -38.09% and a profit margin of -22.85%, with a gross margin of -44.16%. The profit margin, also known as the revenue ratio or gross profit ratio, measures how efficiently a company converts sales into net income; higher margins indicate greater profitability.

In terms of valuation, Beauty Health Co’s market capitalization stands at $219.52 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value. Additionally, the Price-to-Sales Ratio is 0.6, reflecting the market’s valuation of the company’s sales, while the Price-to-Book Ratio is 3.17, comparing the market value to the company’s book value.

Understanding Insider Trading

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 37.64% of Beauty Health Co (SKIN)’s shares, while financial institutions hold 65.71%.

Related Posts